To The Moon: Our Interview With ResearchSat
Recently, I had the chance to sit down and chat with ResearchSat’s founder/CEO RaviTeja Duggineni and their head of investor relations, Rahul Kundnani.
Jumar and its Exciting Impact on Melbourne’s Biotech Sphere
Read this article to discover more about the newest addition to Melbourne’s biotech hub, Jumar Bioincubator! We discuss who the major players and winners are in the development of Jumar.
Eppin Pharma’s Innovative Male Contraceptive…Could This Be The One?
In this article.. Eppin Pharma Inc has been developing a non-hormonal male contraceptive for the last 20 years. Last week in ‘Why Hasn’t Big Pharma Pulled Out A Male Contraceptive Pill?’, we discussed the need for a male contraceptive pill and the reasons why we haven’t seen one on the market yet. In that article, …
Read more “Eppin Pharma’s Innovative Male Contraceptive…Could This Be The One?”
Big day for Aussie biotech: NSB and MSB soar
Two Australian stock exchange listed biotech companies, Neuroscientific Biopharmaceuticals LTD and Mesoblast LTD, have experienced upward spikes in share price as a result of positive news released over the Easter holiday.
Oh, Canada: Exopharm acquire Tryp Therapeutics
In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.
Top 4 Biotech companies to look out for in 2024
In this article.. The biotechnology industry is constantly evolving, with new companies emerging and established players making advancements every day. As we move through 2024, It’s important to recognise which companies are poised to make a significant impact. Currently, the market is leaning optimistically due to the high number of acquisitions into bopharma companies performed …